Tetsuya Nakatsura

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Venues

Cancer science

Journal of hepatocellular carcinoma

This page only lists publications with an associated author ORCID identifier.

Publications

My Viet Thi Ha, Hiroshi Hamana, Kiyomi Shitaoka, Abdul Hayee, Eiji Kobayashi, Toshiaki Yoshikawa, Tetsuya Nakatsura, Reiko Saikawa, Eri Sato, Mitsujiro Osawa, Yasumichi Hitoshi, Son Tung Dang, Tatsuhiko Ozawa, Hiroyuki Kishi
Selection of highly responsive T cell receptors by an analysis combining the expression of multiple markers. Cancer science (2023)
Jimmy Charneau, Toshihiro Suzuki, Manami Shimomura, Norihiro Fujinami, Yuji Mishima, Kazushi Hiranuka, Noriko Watanabe, Takashi Yamada, Norihiro Nakamura, Tetsuya Nakatsura
Development of antigen-prediction algorithm for personalized neoantigen vaccine using human leukocyte antigen transgenic mouse. Cancer science 113 (4) (2022)
Naoki Yagi, Toshihiro Suzuki, Shoichi Mizuno, Motohiro Kojima, Masashi Kudo, Motokazu Sugimoto, Shin Kobayashi, Naoto Gotohda, Genichiro Ishii, Tetsuya Nakatsura
Component with abundant immune-related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis. Cancer science 113 (5) (2022)
Yusuke Yoshioka, Manami Shimomura, Keigo Saito, Hideshi Ishii, Yuichiro Doki, Hidetoshi Eguchi, Tetsuya Nakatsura, Takao Itoi, Masahiko Kuroda, Masaki Mori, Takahiro Ochiya
Circulating cancer-associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer. Cancer science 113 (10) (2022)
Jimmy Charneau, Toshihiro Suzuki, Manami Shimomura, Norihiro Fujinami, Tetsuya Nakatsura
Peptide-Based Vaccines for Hepatocellular Carcinoma: A Review of Recent Advances. Journal of hepatocellular carcinoma 8 (2021)
Hiroyasu Aoki, Satoshi Ueha, Yoshiaki Nakamura, Shigeyuki Shichino, Hiromichi Nakajima, Manami Shimomura, Akihiro Sato, Tetsuya Nakatsura, Takayuki Yoshino, Kouji Matsushima
Greater extent of blood-tumor TCR repertoire overlap is associated with favorable clinical responses to PD-1 blockade. Cancer science 112 (8) (2021)
Yu Akazawa, Yuki Saito, Toshiaki Yoshikawa, Keigo Saito, Kazuto Nosaka, Manami Shimomura, Shoichi Mizuno, Yasunari Nakamoto, Tetsuya Nakatsura
Efficacy of immunotherapy targeting the neoantigen derived from epidermal growth factor receptor T790M/C797S mutation in non-small cell lung cancer. Cancer science 111 (8) (2020)
Masatake Taniguchi, Shoichi Mizuno, Toshiaki Yoshikawa, Norihiro Fujinami, Motokazu Sugimoto, Shin Kobayashi, Shinichiro Takahashi, Masaru Konishi, Naoto Gotohda, Tetsuya Nakatsura
Peptide vaccine as an adjuvant therapy for glypican-3-positive hepatocellular carcinoma induces peptide-specific CTLs and improves long prognosis. Cancer science 111 (8) (2020)
Tatsuki Ueda, Ayako Kumagai, Shoichi Iriguchi, Yutaka Yasui, Tadayo Miyasaka, Kengo Nakagoshi, Kazuki Nakane, Keigo Saito, Mari Takahashi, Aki Sasaki, Shinsuke Yoshida, Naoko Takasu, Hiroshi Seno, Yasushi Uemura, Koji Tamada, Tetsuya Nakatsura, Shin Kaneko
Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells. Cancer science 111 (5) (2020)
Yasuhiro Shimizu, Toshiaki Yoshikawa, Takashi Kojima, Kayoko Shoda, Kazuto Nosaka, Shoichi Mizuno, Satoshi Wada, Yuki Fujimoto, Tetsuro Sasada, Kenichi Kohashi, Hideaki Bando, Itaru Endo, Tetsuya Nakatsura
Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial. Cancer science 110 (10) (2019)
Yu Akazawa, Ako Hosono, Toshiaki Yoshikawa, Hide Kaneda, Chika Nitani, Junichi Hara, Yoshiaki Kinoshita, Kenichi Kohashi, Atsushi Manabe, Miki Fukutani, Masashi Wakabayashi, Akihiro Sato, Kayoko Shoda, Manami Shimomura, Shoichi Mizuno, Yasunari Nakamoto, Tetsuya Nakatsura
Efficacy of the NCCV Cocktail-1 vaccine for refractory pediatric solid tumors: A phase I clinical trial. Cancer science 110 (12) (2019)
Yu Akazawa, Daisuke Nobuoka, Mari Takahashi, Toshiaki Yoshikawa, Manami Shimomura, Shoichi Mizuno, Toshiyoshi Fujiwara, Yasunari Nakamoto, Tetsuya Nakatsura
Higher human lymphocyte antigen class I expression in early-stage cancer cells leads to high sensitivity for cytotoxic T lymphocytes. Cancer science 110 (6) (2019)
Yasuhiro Shimizu, Shoichi Mizuno, Norihiro Fujinami, Toshihiro Suzuki, Keigo Saito, Masaru Konishi, Shinichiro Takahashi, Naoto Gotohda, Toshifumi Tada, Hidenori Toyoda, Takashi Kumada, Masahiro Miura, Kouzou Suto, Taiki Yamaji, Takahisa Matsuda, Itaru Endo, Tetsuya Nakatsura
Plasma and tumoral glypican-3 levels are correlated in patients with hepatitis C virus-related hepatocellular carcinoma. Cancer science 111 (2) (2019)
Ken Imaizumi, Toshihiro Suzuki, Motohiro Kojima, Manami Shimomura, Naoki Sakuyama, Yuichiro Tsukada, Takeshi Sasaki, Yuji Nishizawa, Akinobu Taketomi, Masaaki Ito, Tetsuya Nakatsura
Ki67 expression and localization of T cells after neoadjuvant therapies as reliable predictive markers in rectal cancer. Cancer science 111 (1) (2019)

Tetsuya Nakatsura.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tetsuya Nakatsura